← Leaderboards
Jonathan D. Chernoff
Institute For Cancer Research
$26,792,751
Attributed
$28,779,254
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,001,085 · 12
By mechanism
R01$16,395,684 · 6
C06$8,000,000 · 1
P30$7,132,870 · 3
T32$3,446,531 · 1
R13$26,000 · 1
Top collaborators
- Joseph Robert Testa10 shared
Most similar at Institute For Cancer Research
Same institution · by research overlap
- Peter D. Adams$32,646,359
- Myung K Shin$1,010,000
- John Burch$2,893,835
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBaseSignal TransductionTumorCellsSignal PathwayBiologicalTumorigenesisTherapeutic TargetPositioning AttributeCell MotilityPlayCell ProliferationPhosphotransferasesMolecularMemberIn VivoGeneticP21 Activated KinasePathway InteractionsResistanceGrowthAffectInhibitor/Antagonist
Grant awards (75)
Leadership, Planning and Evaluation$278,051
P30 · FY2025 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$419,207
R01 · FY2022 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$400,000
P30 · FY2022 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$250,000
P30 · FY2022 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$1,035,145
P30 · FY2021 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$427,763
R01 · FY2021 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$400,000
P30 · FY2021 · CA · contact PI
Cancer Biology Program (01)$400,000
P30 · FY2021 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$250,000
P30 · FY2021 · CA · contact PI
Cancer Biology Program (01)$7,133
P30 · FY2021 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$3,105,436
P30 · FY2020 · CA · contact PI
Training Program in Cancer Research$640,130
T32 · FY2020 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$556,548
R01 · FY2020 · CA · contact PI
Role of STE20 protein kinases in malignant mesothelioma$444,125
R01 · FY2020 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$391,000
P30 · FY2020 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$250,000
P30 · FY2020 · CA · contact PI
Comprehensive Cancer Center Program at Fox Chase$140,250
P30 · FY2020 · CA · contact PI
Cancer Biology Program (01)$45,024
P30 · FY2020 · CA · contact PI
Cancer Biology Program (01)$8,695
P30 · FY2020 · CA · contact PI
Training Program in Cancer Research$605,277
T32 · FY2019 · CA · contact PI
Targeting the Kinome in Neurofibromatosis type 1$421,586
R01 · FY2019 · CA · contact PI
Role of STE20 protein kinases in malignant mesothelioma$421,586
R01 · FY2019 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$414,929
R01 · FY2019 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$124,920
R01 · FY2019 · CA · contact PI
Cancer Biology Program (01)$42,123
P30 · FY2019 · CA · contact PI
Training Program in Cancer Research$595,130
T32 · FY2018 · CA · contact PI
Targeting the Kinome in Neurofibromatosis type 1$434,625
R01 · FY2018 · CA · contact PI
Role of STE20 protein kinases in malignant mesothelioma$434,625
R01 · FY2018 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$418,613
R01 · FY2018 · CA · contact PI
Targeting the Rac1 signaling pathway in malignant melanoma$97,268
R01 · FY2018 · CA · contact PI
Cancer Biology Program (01)$38,271
P30 · FY2018 · CA · contact PI
Cancer Biology Program (01)$10,869
P30 · FY2018 · CA · contact PI
Cancer Biology Program (01)$5,967
P30 · FY2018 · CA · contact PI
Training Program in Cancer Research$500,578
T32 · FY2017 · CA · contact PI
Role of STE20 protein kinases in malignant mesothelioma$434,625
R01 · FY2017 · CA · contact PI
Targeting the Kinome in Neurofibromatosis type 1$434,625
R01 · FY2017 · CA · contact PI
Cancer Biology Program (01)$38,269
P30 · FY2017 · CA · contact PI
Training Program in Cancer Research$539,790
T32 · FY2016 · CA · contact PI
Role of STE20 protein kinases in malignant mesothelioma$423,938
R01 · FY2016 · CA · contact PI
Targeting the Kinome in Neurofibromatosis type 1$423,938
R01 · FY2016 · CA · contact PI
Cancer Biology Program (01)$36,637
P30 · FY2016 · CA · contact PI
Training Program in Cancer Research$565,626
T32 · FY2015 · CA · contact PI
Targeting the Kinome in Neurofibromatosis type 1$423,938
R01 · FY2015 · CA · contact PI
The Role of p21-Activated Kinases in Malignant Mesothelioma$370,388
R01 · FY2015 · CA · contact PI
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1$392,060
R01 · FY2014 · CA · contact PI
The Role of p21-Activated Kinases in Malignant Mesothelioma$359,276
R01 · FY2014 · CA · contact PI
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1$379,935
R01 · FY2013 · CA · contact PI
The Role of p21-Activated Kinases in Malignant Mesothelioma$348,165
R01 · FY2013 · CA · contact PI
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1$395,129
R01 · FY2012 · CA · contact PI
The Role of p21-Activated Kinases in Malignant Mesothelioma$369,695
R01 · FY2012 · CA · contact PI
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1$395,129
R01 · FY2011 · CA · contact PI
The Role of p21-Activated Kinases in Malignant Mesothelioma$366,583
R01 · FY2011 · CA · contact PI
2007 Mechanisms of Cell Signalling Gordon Research Conference$6,000
R13 · FY2011 · CA · contact PI
Signaling by p21-activated protein kinases$380,860
R01 · FY2010 · CA · contact PI
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1$181,044
R01 · FY2010 · CA · contact PI
Addition and Expansion of Laboratory Animal Research Fa*$8,000,000
C06 · FY2009 · RR · contact PI
Signaling by p21-activated protein kinases$373,393
R01 · FY2009 · CA · contact PI
2007 Mechanisms of Cell Signalling Gordon Research Conference$10,000
R13 · FY2009 · CA · contact PI
Signaling by p21-activated protein kinases$355,245
R01 · FY2008 · CA · contact PI
A Growth-Regulating Protein Tyrosine Phosphatase$376,570
R01 · FY2007 · CA · contact PI
Signaling by p21-activated protein kinases$351,728
R01 · FY2007 · CA · contact PI
2007 Mechanisms of Cell Signalling Gordon Research Conference$10,000
R13 · FY2007 · CA · contact PI
A Growth-Regulating Protein Tyrosine Phosphatase$387,817
R01 · FY2006 · CA · contact PI
Signaling by p21-activated protein kinases$360,786
R01 · FY2006 · CA · contact PI
A Growth-Regulating Protein Tyrosine Phosphatase$397,542
R01 · FY2005 · CA
A Growth-Regulating Protein Tyrosine Phosphatase$399,500
R01 · FY2004 · CA
Regulation of P21-Activated Kinases$275,517
R01 · FY2004 · GM
A Growth-Regulating Protein Tyrosine Phosphatase$467,500
R01 · FY2003 · CA
Regulation of P21-Activated Kinases$271,592
R01 · FY2003 · GM
TUMOR SUPPRESSING PROTEIN TYROSINE PHOSPHATASE$320,538
R01 · FY2002 · CA
Regulation of P21-Activated Kinases$259,894
R01 · FY2002 · GM
TUMOR SUPPRESSING PROTEIN TYROSINE PHOSPHATASE$311,201
R01 · FY2001 · CA
Regulation of P21-Activated Kinases$267,931
R01 · FY2001 · GM
TUMOR SUPPRESSING PROTEIN TYROSINE PHOSPHATASE$302,137
R01 · FY2000 · CA
REGULATION OF P21-ACTIVATED KINASES$221,670
R01 · FY2000 · GM